Catalytic Impact Foundation
FoundationHingham · Pre-Seed–Series A · 8 people tracked
Find your way into Catalytic Impact Foundation
Sign up to see every warm intro you have to Catalytic Impact Foundation
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Catalytic Impact Foundation team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The foundation accelerates innovation in life sciences and healthcare by deploying philanthropic capital into early-stage companies developing transformative, life-sustaining technologies. It targets the funding gap known as the 'Valley of Death' between research grants and commercial investment. Investments focus on six underfunded verticals: children's health, brain and mental health, women's health, rare diseases, health equity, and healthy aging. Its capital is catalytic, aiming to validate technologies and teams to attract further investment while helping companies advance toward FDA approval. The foundation also prioritizes women-led companies, citing their strong returns despite receiving little venture funding.
Source: firm website, verified Oct 2, 2026.
Team · 8 people
from the firm's websiteWhat they invest in
from 20 of 57 portfolio companiesHealthtech ×10Biotech ×9Medical Devices ×8AI & Machine Learning ×7Digital Health ×6FemTech ×4Advanced Manufacturing ×1Cleantech ×1
HQs:United States×17Ireland×1
Who they back
founder profiles across 14 portfolio companiesFounding team size:solo founder×32 founders×73 founders×4
Where their founders studiedfrom 14 founders with education data
Massachusetts Institute of Technology ×3Columbia University ×2Sapienza Università di Roma ×2
What their founders studiedfrom 15 founders with field-of-study data
Engineering ×5Business & Management ×4Computer Science ×4Economics ×2Finance & Accounting ×2Humanities ×2Medicine ×2
Where their founders worked beforefrom 17 founders with career history
Google ×2Polaris Partners ×2SUNY Downstate Medical Center ×2
Investments · 57 tracked
founders shown can be your intro pathBy year:2025 · 12017 · 12 dated
CB Insights provides a market intelligence platform that offers verified data, analytics, and predictive scoring on over 12 million private and public companies.
AI & Machine LearningData & InfrastructureSaaS
Co-investorsAlumni VenturesBasecamp FundCartaCRV (Charles River Ventures)Essentia VenturesInCountry+7 more
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US
Oriana Papin-Zoghbi(Founder)inAlex Fisher(COO)inAnna Jeter(Founder)inOriana Zoghbi-Harb(Executive Officer, Director)Abigail Mcelhinny(Executive Officer)inRob Mayers(Recruiter)
Co-investorsAlleyCorpGood Growth CapitalJoyance PartnersY CombinatorAstiaAurum Venture Partners+37 more
Applied Intuition develops physical AI software for autonomous and intelligent machines, including vehicles, robots, ships, and satellites across industries like automotive, defense, logistics, and manufacturing.
AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareRoboticsSunnyvale, US
Qasar Younis(Founder)inPeter Ludwig(Founder)inQasar Younis Peter Ludwig(Founder)
Co-investors137 VenturesAndreessen HorowitzBond Capital ManagementCoatue ManagementElad GilEQUIAM+33 more
Bloomer Tech develops digital biomarkers and precision cardiovascular care built around female physiology.
Digital HealthFemTechMedical Devices
Alicia Chong Rodriguez(Founder & CEO)inAceil Halaby(Founder & COO)in
Co-investorsMaterial Impact
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Founder)
BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)inLouis Samson(Director)
Co-investorsBattery VenturesBreyer CapitalDigiTx Partners LLCEsplanade VenturesInsight PartnersLRVHealth+6 more
Concarlo Therapeutics develops cancer therapeutics that target CDK4/6-driven cell proliferation and CDK2-driven resistance, focusing on improving outcomes for cancer patients through novel approaches in p27 biology.
BiotechBrooklyn, US
Stacy Blain(Founder, CEO)inLisaMarie Casey(President and Manager)
BoardJason Mraz(Executive Board Member)in
Co-investorsBioAdvanceCreative Destruction Lab (CDL)Raptor Group
DeepEcho develops AI-powered intelligent ultrasound technology to detect birth defects, preterm birth, and low birth weight in newborns.
AI & Machine LearningDigital HealthFemTechHealthtechMedical Devices
Youssef Bouyakhf(Founder)in
Co-investorsAsia Africa Investment & Consulting (AAIC)UM6P VenturesAlgebra Ventures
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical DevicesNew York, US
Nina Tandon(Co-Founder, CEO)inSarindr Bhumiratana(Co-Founder)inGordana Vunjak-Novakovic(Director)Elma Hawkins(Director)
BoardRobert Langer(Director)David Zhu(Director)in
Co-investorsBeresford VenturesEMV CapitalHackensack Meridian Health Bear's DenKendall Capital PartnersLifespan Vision VenturesMEDA Angels+3 more
Fierce Life Sciences provides news, analysis, and event education for the biopharma and life sciences industry, covering stages from preclinical research through market.
BiotechMedia & Entertainment
LunaJoy is a mental health platform that connects women facing postpartum challenges with mental health providers.
Digital HealthFemTechHealthtechMental HealthAtlanta, US
Sipra Laddha(Founder)inShama Rathi(Founder)inLiana Felt(Recruiting)Nathalie Alcala(Recruiter)Jill Chami(HR Director)Carrers LunaJoy(Recruiter)
Co-investorsAwareness VentureEmmeline VenturesFoundersX VenturesK20 FundNurture Venture PartnersVentureSouq+8 more
Chicago-based medical device company developing the SmartShunt smart electromechanical shunt system for hydrocephalus.
HealthtechChicago, US
Tyler Wanke(Executive Officer, Director)inBermans Iskandar(Director)Joshua Medow(Executive Officer, Director)
BoardJoshua Carson(Director)inJohn Slump(Director)
Co-investorsIllinois VenturesmHUBEndeavor Health Ventures
NUA Surgical develops surgical medical devices focused on maternal and infant health, currently in pre-clinical development.
FemTechHealthtechMedical DevicesGalway, IE
Barry(CEO & Founder)inMarie Therese(COO & Co-Founder)inPadraig(CTO & Co-Founder)
Co-investorsTMC Venture FundEnterprise IrelandEQT Life Sciences
OffGridBox provides integrated systems combining renewable energy generation and water purification for households and institutions such as health clinics and schools, including in humanitarian settings like refugee camps.
CleantechClimate TechEnergyFintechSomerville, US
Emiliano Cecchini(Co-founder & CTO)inDavide Bonsignore(Co-founder & Global Director)inBas Berends(Chief Executive Officer)in
BoardJodie Wu(Board Chair)
Co-investorsTechstars
OtoNexus Medical Technologies is developing an ultrasound-based otoscope (Novoscope) that uses a miniaturized sensor in a single-use ear speculum tip to give clinicians objective, point-of-care data on middle-ear fluid and infection type.
AI & Machine LearningDigital HealthHardwareHealthtechMedical DevicesSeattle, US
Caitlin Cameron(Chair & CEO)in
Co-investorsGolden SeedsDellin InvestmentsFarvatn VentureKeiretsu ForumMindshift CapitalPlanet 9 Capital+5 more
BiotechBethesda, US
Andrea Barthwell(Director)Behshad Sheldon(Director)Ashanthi Mathai(Executive Officer, Director)Serena Kim(Executive Officer)Kathryn Bowsher(Director)
Co-investorsKern Venture GroupMedMountain VenturesStartX
Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.
BiotechHealthtechMedical DevicesSeattle, US
Richard Mulligan(Director)inHans Bishop(Founder)Steve Harr(Founder)James J. MacDonald(Executive Officer)Nathan Hardy(Executive Officer)
BoardGeoffrey von Maltzahn(Director)in
Co-investorsAmerican Family VenturesARCH Venture PartnersF-Prime CapitalFlagship PioneeringGV (Google Ventures)Innovating Capital+8 more
Baltimore, US
Ellington West(Executive Officer, Director, Promoter)Ian McLane(Executive Officer, Director)Jaishree McLane(Executive Officer, Director, Promoter)Brandon Dottin-Haley(Executive Officer, Director, Promoter)
BoardIlene Busch-Vishniac(Executive Officer, Director, Promoter)Leslie Wise(Director)
Co-investorsSand Hill Angels
Stingray is an oncology-focused biotech company developing drugs from discovery through clinical development to commercialization, led by scientists and physicians with experience in building oncology companies.
AI & Machine LearningBiotechHealthtechHouston, US
Jonathan Northrup(Chief Executive Officer, Co-Founder)inSunil Sharma(Chief Medical Officer, Co-Founder)inScott Andrew Jordan(Executive Officer, Director, Promoter)
Co-investorsGreen Park & Golf Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlioAltoAOAAOA DiagnosticsAtai BeckleyAZTherapiesBicaraCeretypeCulturintelDeck TherapeuticsDionysusEgalEgal PadsEpiVaxFeminaiFlourishGeneiusLimaxLyndraMassiveBioMelioMicrobionNeuraxisNeuroRXOCONOncoheroesOrigamiPisonPyramesRaydiantRejuvenationSIAStarlightStemonixTerranTriajTvardiWavelyXtherma
Portfolio news
latest coverage across their companiesApplied Intuition · techcrunch.com · Jun 17, 2025
Frequently asked questions
- How many investments has Catalytic Impact Foundation made?
- Catalytic Impact Foundation has 57 tracked investments, including 1 dated in the last 24 months.
- What stage does Catalytic Impact Foundation invest at?
- Catalytic Impact Foundation invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Catalytic Impact Foundation focus on?
- Catalytic Impact Foundation focuses on Biotech, Digital Health, FemTech, Healthtech, Impact & Social Good, Longevity, Medical Devices, Mental Health.
- Where is Catalytic Impact Foundation located?
- Catalytic Impact Foundation is headquartered in Hingham, US.
- Who does Catalytic Impact Foundation co-invest with?
- Catalytic Impact Foundation most often shares deals with Sand Hill Angels, Andreessen Horowitz, Battery Ventures, among 95 tracked co-investors.
Media · Podcasts & interviews
featuring the teamRachel Butler, President, Catalytic Impact|TBCY
The Brand Called You · Rachel Butler
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.
IKJ Capital is a venture capital firm investing in early-stage healthcare technology companies, with a focus on mental health, chronic conditions, and longevity. It operates across the Americas from Palo Alto, New York, and São Paulo.
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Coyote Ventures is an investor focused on democratizing healthcare access for overlooked and underserved populations through innovation.





















































































.jpg?itok=YnNGtnt9)











